Mast cells in atherogenesis: Actions and reactions

Current Atherosclerosis Reports

Volumn 11, Issue 3, 2009, Pages 214-219

  Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; HISTAMINE; LIPOPROTEIN; NEUTRAL PROTEINASE;

ALLERGIC ASTHMA; ANTIGEN ANTIBODY COMPLEX; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; CELL FUNCTION; CELL GRANULE; CHRONIC INFLAMMATION; EFFECTOR CELL; EXOCYTOSIS; EXTRACELLULAR MATRIX; HEART INFARCTION; HUMAN; IMMUNOHISTOLOGY; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; HUMANS; MAST CELLS; TUNICA INTIMA;

EID: 65449176409     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-009-0033-7     Document Type: Review

References (41)

1. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352: 1685-1695.
2. KovaneM PT: Mast cells: multipotent local effector cells in atherothrombosis. Immunol Rev 2007, 217: 105-122.
3. Tabas I, Williams KJ, Borén J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation 2007, 116: 1832-1844.
4. Kelley J, Hemontolor G, Younis W, et al.: Mast cell activation by lipoproteins. Methods Mol Biol 2006, 315: 341-348.
5. Lindstedt KA, Mäyränpää MI, Kovanen PT: Mast cells in vulnerable atherosclerotic plaques-a view to a kill. J Cell Mol Med 2007, 11: 739-758.
6. Mäyränpää MI, Heikkil: Desquamation of human coronary artery endothelium by human mast cell proteases: Implications for plaque erosion. Coronary Artery Dis 2006, 17: 611-621.
7. Miyamoto T, Sasaguri Y, Sasaguri T, et al.: Expression of stem cell factor in human aortic endothelial and smooth muscle cells. Atherosclerosis 1997, 129: 207-213.
8. Haley KJ, Lilly CM, Yang JH, et al.: Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: Using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 2000, 102: 2185-2189.
9. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6: 135-142.
10. Laine P, Kaartinen M, Penttil: Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999, 99: 361-369.
11. Lappalainen H, Laine P, Pentikäinen MO, et al.: Mast cells in neovascularized human coronary plaques store and secrete basic fibroblast growth factor, a potent angiogenic mediator. Arterioscler Thromb Vasc Biol 2004, 24: 1880-1885.
12. Stevens RL, Adachi R: Protease-proteoglycan complexes of mouse and human mast cells and importance of their betatryptase-heparin complexes in inflammation and innate immunity. Immunol Rev 2007, 217: 155-167.
13. Lappalainen J, Lindstedt KA, Kovanen PT: A protocol for generating high numbers of mature and functional human mast cells from peripheral blood. Clin Exp Allergy 2007, 37: 1404-1412.
14. Irani AA, Craig SS, Nilsson G, et al.: Characterization of human mast cells developed in vitro from fetal liver cells cocultured with murine 3T3 fibroblasts. Immunology 1992, 77: 136-143.
15. Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al.: Mast cells as "tunable" effector and immunoregulatory cells: Recent advances. Annu Rev Immunol 2005, 23: 749-786.
16. Kaartinen M, Penttil: Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-alpha. Circulation 1996, 94: 2787-2792.
17. Kovanen PT, Kaartinen M, Paavonen T: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995, 92: 1084-1088.
18. Galli SJ, Dvorak AM,MDvorak HF: Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984, 34: 1-141.
19. Kawakami T, Galli SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002, 2: 773-786.
20. Kounis NG: Kounis syndrome (allergic angina and allergic myocardial infarction): A natural paradigm? Int J Cardiol 2006, 110: 7-14.
21. Kovanen PT: Mast cells and degradation of pericellular and extracellular matrices: Potential contributions to erosion, rupture and intraplaque haemorrhage of atherosclerotic plaques. Biochem Soc Trans 2007, 35: 857-861.
22. Kaartinen M, Penttil Kovanen PT: Extracellular mast cell granules carry apolipoprotein B-100-containing lipoproteins into phagocytes in human arterial intima: Functional coupling of exocytosis and phagocytosis in neighboring cells. Arterioscler Thromb Vasc Biol 1995, 15: 2047-2054.
23. Dvorak AM: Piecemeal degranulation of basophils and mast cells is effected by vesicular transport of stored secretory granule contents. Chem Immunol Allergy 2005, 85: 135-184.
24. Gordon JR, Galli SJ: Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990, 346: 274-276.
25. Theoharides TC, Kempuraj D, Tagen M, et al.: Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev 2007, 217: 65-78.
26. Fischer M, Harvima IT, Carvalho RF, et al.: Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J Clin Invest 2006, 116: 2748-2756.
27. Boyle JJ: Association of coronary plaque rupture and atherosclerotic inflammation. J Pathol 1997, 181: 93-99.
28. Boyce JA: Mast cells and eicosaAoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 2007, 217: 168-185.
29. Bäck M, Hansson GK: Leukotriene receptors in atherosclerosis. Ann Med 2006, 38: 493-502.
30. BachelNt I, Levi-Schaffer F, Mekori YA: Mast cells: not only in allergy. Immunol Allergy Clin North Am 2006, 26: 407-425.
31. Oksjoki R, Kovanen PT, Meri S, Pentikäinen MO: Function and regulation of the complement system in cardiovascular diseases. Front Biosci 2007, 12: 4696-4708.
32. Oksjoki R, Laine P, Helske S, et al.: Receptors for the anaphylatoxin C3aR and C5aR are expressed in human atherosclerotic coronary plaques. Atherosclerosis 2007, 195: 90-99.
33. Baumann U, Chouchakova N, Gewecke B, et al.: Distinct tissue site-specific requirements of mast cells and complement components C3/ C5a receptor in IgG immune complex-induced injury of skin and lung. J Immunol 2001, 167: 1022-1027.
34. YläHerttuala S, Palinski W, Butler SW, et al.: Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 1994, 14: 32-40.
35. Ma H, Kovanen PT: Degranulation of cutaneous mast cells induces transendothelial transport and local accumulation of plasma LDL in rat skin in vivo. J Lipid Res 1997, 38: 1877-1887.
36. Kokkonen JO: Stimulation of rat peritoneal mast cells enhances uptake of low density lipoproteins by rat peritoneal macrophages in vivo. Atherosclerosis 1989, 79: 213-223.
37. Lee-Rueckert M,PKovanen PT: Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport. Atherosclerosis 2006, 189: 8-18.
38. Libby P, Shi GP: Mast cells as mediators and modulators of atherogenesis. Circulation 2007, 115: 2471-2473.
39. Sun J, Sukhova GK, Wolters PJ, et al.: Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007, 13: 719-724.
40. Bot I, de Jager SC, Zernecke A, et al.: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007, 115: 2516-2525.
41. Metz M, Grimbaldeston MA, Nakae S, et al.: Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217: 304-328.